Bausch Health Companies BHC
NYSE BHC
$6.44 -0.37 (-5.43%)
At close: Aug 21, 2026 · 4:00 PM EDT

Bausch Health Companies (BHC) Non Operating Investment Income (2010 - 2014)

Bausch Health Companies (BHC) posted Non Operating Investment Income of $287.1 million for Q4 2014, up 8344.12% sequentially from $3.4 million in Q3 2014.

Bausch Health Companies (BHC) Non Operating Investment Income (2010 - 2014) Analysis & Trends

Bausch Health Companies has reported Non Operating Investment Income for 5 years, with the latest figure at $287.1 million in Q4 2014.

  • Quarterly Non Operating Investment Income changed N/A year-over-year to $287.1 million in Q4 2014, while the trailing twelve-month figure through Dec 2015 was $287.1 million (down 2.01% YoY) and the FY2014 annual result came in at $293.0 million, up 4951.72% from the prior year.
  • Non Operating Investment Income grew to $287.1 million in Q4 2014 per BHC's latest filing, from $3.4 million in the prior quarter.
  • Over five years, Non Operating Investment Income peaked at $287.1 million in Q4 2014 and troughed at -$5.0 million in Q3 2010.
  • A 5-year average of $21.2 million and a median of $1.8 million in 2011 frame the typical range for Non Operating Investment Income.
  • The sharpest annual moves came in 2012 and 2013: Non Operating Investment Income tumbled 100.17% in 2012, then surged 11242.86% in 2013.
  • Over 5 years, Non Operating Investment Income stood at -$5.0 million in 2010, then soared by 99.78% to -$11000.0 in 2011, then surged by 790.91% to $76000.0 in 2012, then soared by 5031.58% to $3.9 million in 2013, then surged by 7261.54% to $287.1 million in 2014.
  • According to Business Quant data, Non Operating Investment Income over the past three periods registered $287.1 million, $3.4 million, and $2.5 million for Q4 2014, Q3 2014, and Q2 2014 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Bausch Health Companies 2.42 Bn 586.38 Mn 2.10 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2014 287.10 Mn
Dec 31, 2014 287.10 Mn
Sep 30, 2014 3.40 Mn
Sep 30, 2014 3.40 Mn
Jun 30, 2014 2.50 Mn
Jun 30, 2014 2.50 Mn
Jun 30, 2013 3.90 Mn
Jun 30, 2013 3.90 Mn
Mar 31, 2013 1.86 Mn
Mar 31, 2013 1.86 Mn
Dec 31, 2012 76,000.00
Dec 31, 2012 76,000.00
Jun 30, 2012 -35,000.00
Jun 30, 2012 -35,000.00
Mar 31, 2012 2.06 Mn
Mar 31, 2012 2.06 Mn
Dec 31, 2011 -11,000.00
Dec 31, 2011 -11,000.00
Sep 30, 2011 -140,000.00
Sep 30, 2011 -140,000.00